Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine

被引:18
作者
Wu, Fan [1 ]
Yuan, Xiao-Yi [1 ]
Huang, Wei-Shan [1 ]
Chen, Ying-Hua [1 ]
机构
[1] Tsinghua Univ, Immunol Lab, Dept Biol, Beijing Key Lab Prot Therapeut, Beijing 100084, Peoples R China
关键词
Influenza virus; Combined vaccination; M2e; Split influenza vaccine; Heterosubtypic protection; PANDEMIC CONTROL STRATEGIES; EXTRACELLULAR DOMAIN; AVIAN INFLUENZA; A H5N1; VIRUS; IMMUNITY; PROTEIN; MICE; INFECTION;
D O I
10.1016/j.vaccine.2008.11.037
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There is urgent need to develop influenza vaccines with broad-spectrum protection against the potential influenza pandemic. The extracellular domain of influenza M2 protein (M2e) is considered as an appropriate target to induce heterosubtypic protection. We investigated the immunity and protection induced by combined vaccination with synthetic M2e peptide and traditional split influenza vaccine. The combined vaccination was able to induce similar strain-specific hemagglutinin inhibition (HI) antibodies as vaccination of split virus alone. However, aluminum-adjuvant but not oil-in-water-emulsion adjuvant combined vaccination was able to induce high titers of anti-M2e antibodies and provoke M2e-specific T lymphocyte response. Furthermore, we found that the addition of M2e peptide greatly enhanced the cross-protective efficacy of split virus in aluminum adjuvant but slightly weakened the efficacy of vaccination in oil-in-water-emulsion adjuvant. Moreover, aluminum-adjuvant combined vaccination conferred complete cross-protection against heterosubtypic influenza virus. According to the results, we suggest that the M2e peptide should be added into split influenza vaccine in the preparation for the potential influenza pandemic. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6095 / 6101
页数:7
相关论文
共 50 条
  • [41] Expression of the nucleotide sequence for the M2e peptide of avian influenza virus in transgenic tobacco plants
    I. V. Tarasenko
    A. I. Taranov
    A. P. Firsov
    S. V. Dolgov
    Applied Biochemistry and Microbiology, 2013, 49 : 695 - 701
  • [42] An Inactivated Influenza Virus Vaccine Approach to Targeting the Conserved Hemagglutinin Stalk and M2e Domains
    Sun, Weina
    Zheng, Allen
    Miller, Robert
    Krammer, Florian
    Palese, Peter
    VACCINES, 2019, 7 (03)
  • [43] Characterization of immunity induced by M2e of influenza virus
    Wu, Fan
    Huang, Jing-He
    Yuan, Xiao-Yi
    Huang, Wei-Shan
    Chen, Ying-Hua
    VACCINE, 2007, 25 (52) : 8868 - 8873
  • [44] Protection against Multiple Influenza A Virus Strains Induced by Candidate Recombinant Vaccine Based on Heterologous M2e Peptides Linked to Flagellin
    Stepanova, Liudmila A.
    Kotlyarov, Roman Y.
    Kovaleva, Anna A.
    Potapchuk, Marina V.
    Korotkov, Alexandr V.
    Sergeeva, Mariia V.
    Kasianenko, Marina A.
    Kuprianov, Victor V.
    Ravin, Nikolai V.
    Tsybalova, Liudmila M.
    Skryabin, Konstantin G.
    Kiselev, Oleg I.
    PLOS ONE, 2015, 10 (03):
  • [45] Safe Recombinant Outer Membrane Vesicles that Display M2e Elicit Heterologous Influenza Protection
    Watkins, Hannah C.
    Rappazzo, C. Garrett
    Higgins, Jaclyn S.
    Sun, Xiangjie
    Brock, Nicole
    Chau, Annie
    Misra, Aditya
    Cannizzo, Joseph P. B.
    King, Michael R.
    Maines, Taronna R.
    Leifer, Cynthia A.
    Whittaker, Gary R.
    DeLisa, Matthew P.
    Putnam, David
    MOLECULAR THERAPY, 2017, 25 (04) : 989 - 1002
  • [46] Development of live attenuated Bordetella pertussis strains expressing the universal influenza vaccine candidate M2e
    Li, Rui
    Lim, Annabelle
    Ow, Stephanie T. L.
    Phoon, Meng Chee
    Locht, Camille
    Chow, Vincent T.
    Alonso, Sylvie
    VACCINE, 2011, 29 (33) : 5502 - 5511
  • [47] Potential recombinant vaccine against influenza A virus based on M2e displayed on nodaviral capsid nanoparticles
    Yong, Chean Yeah
    Yeap, Swee Keong
    Ho, Kok Lian
    Omar, Abdul Rahman
    Tan, Wen Siang
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2015, 10 : 2751 - 2763
  • [48] Immunogenicity of Live Attenuated B. pertussis BPZE1 Producing the Universal Influenza Vaccine Candidate M2e
    Kammoun, Hana
    Roux, Xavier
    Raze, Dominique
    Debrie, Anne-Sophie
    De Filette, Marina
    Ysenbaert, Tine
    Mielcarek, Nathalie
    Saelens, Xavier
    Fiers, Walter
    Locht, Camille
    PLOS ONE, 2013, 8 (03):
  • [49] A Novel M2e Based Flu Vaccine Formulation for Dogs
    Leclerc, Denis
    Rivest, Marie
    Babin, Cindy
    Lopez-Macias, Constantino
    Savard, Pierre
    PLOS ONE, 2013, 8 (10):
  • [50] Protection against homo and hetero-subtypic infuenza A virus by optimized M2e DNA vaccine
    Yao, Yanfeng
    Wang, Huadong
    Chen, Jianjun
    Shao, Zhiyong
    He, Bin
    Chen, Jie
    Lan, Jiaming
    Chen, Quanjiao
    Chen, Ze
    EMERGING MICROBES & INFECTIONS, 2019, 8 (01): : 45 - 54